Modeling the Prognostic Impact of Circulating Tumor Cells Enumeration in Metastatic Breast Cancer for Clinical Trial Design Simulation
Lorenzo Gerratana(National Cancer Institute), Massimo Cristofanilli(Cornell University), Fabio Puglisi(University of Udine), Jean‐Yves Pierga(Université Paris Cité), Ángela Fernández de Lascoiti(Universidad de Navarra), Daniele Generali(University of Trieste), Salvatore Grisanti(Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia), Luc Dirix(GZA Ziekenhuizen Campus Sint-Augustinus), Paola Gazzaniga(Sapienza University of Rome), Firas Wehbe(Northwestern University), Carmine De Angelis(Baylor College of Medicine), Rita Zamarchi(Istituto Oncologico Veneto), José Á. García-Sáenz(Hospital Clínico San Carlos), James M. Reuben(The University of Texas MD Anderson Cancer Center), Luís Manso(Research Institute Hospital 12 de Octubre), Maria Teresa Sandri(IRCCS Humanitas Research Hospital), Wolfgang Janni(Grace (United States)), Klaus Pantel(Universität Hamburg), Erich‐Franz Solomayer(Saarland University), Rafael Gisbert‐Criado(Hospital Arnau de Vilanova), Mario Giuliano(Regione Campania), Michail Ignatiadis(Université Libre de Bruxelles), Vicente Carañana(Hospital Arnau de Vilanova), Sabine Riethdorf(Universität Hamburg), Justin Stebbing(Anglia Ruskin University), Franco Nolè(European Institute of Oncology), Leticia De Mattos‐Arruda(Universitat Autònoma de Barcelona), Tanja Fehm(Düsseldorf University Hospital), Carlos Caldas(University of Cambridge), Sarah‐Jane Dawson(The University of Melbourne), Andrew A. Davis(Washington University in St. Louis), François‐Clément Bidard(Inserm), Dimitriοs Mavroudis(University of Crete), Marta Bonotto(University of Udine)
Cited by 13
Related Papers
Signatures of mutational processes in human cancer
|Nature|2013|10.1k
Trastuzumab Deruxtecan in Previously Treated HER2-Low Advanced Breast Cancer
|New England Journal of Medicine|2022|2.5k
3rd ESO–ESMO International Consensus Guidelines for Advanced Breast Cancer (ABC 3)
|Annals of Oncology|2016|2.1k
70-Gene Signature as an Aid to Treatment Decisions in Early-Stage Breast Cancer
|New England Journal of Medicine|2016|2k
PI3K/AKT/mTOR signaling transduction pathway and targeted therapies in cancer
|Molecular Cancer|2023|1.9k